comparemela.com

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Thursday, October 6, 2022, at 8:00 a.m. (ET) to report top-line results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 (methotrexate injection, United States Pharma...

Related Keywords

Scott Solomon ,States Pharmacopeia ,Sharon Merrill Associates Inc ,Linkedin ,Twitter ,Facebook ,Aldeyra Therapeutics Inc ,Nasdaq ,Aldeyra Therapeutics ,United States Pharmacopeia ,Merrill Associates ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.